These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 7915305

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Infant with 3β-hydroxy-Δ(5)-C27 steroid dehydrogenase deficiency: report of two cases and literatures review].
    Li X, Huang Z, Wang H.
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):360-5. PubMed ID: 26080666
    [Abstract] [Full Text] [Related]

  • 4. An infant with 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase deficiency presenting with typical neonatal hepatitis syndrome: the first Japanese case.
    Terazawa S, Kimura A, Inoue T, Murai T, Kurosawa T, Takao A.
    Acta Paediatr Jpn; 1998 Dec; 40(6):638-40. PubMed ID: 9893307
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Progressive familial intrahepatic cholestasis and hereditary anomalies lf hepatocellular metabolism of bile acids].
    Jacquemin E.
    Arch Pediatr; 1998 Jan; 5(1):45-53. PubMed ID: 10223112
    [Abstract] [Full Text] [Related]

  • 10. [Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders].
    Kondo KH, Maeda Y, Setoguchi T.
    Ryoikibetsu Shokogun Shirizu; 1995 Jan; (8):362-6. PubMed ID: 8581653
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholestatic liver disease in adults may be due to an inherited defect in bile acid biosynthesis.
    Fischler B, Bodin K, Stjernman H, Olin M, Hansson M, Sjövall J, Björkhem I.
    J Intern Med; 2007 Aug; 262(2):254-62. PubMed ID: 17645593
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inborn errors of metabolism with consequences for bile acid biosynthesis. A minireview.
    Björkhem I.
    Scand J Gastroenterol Suppl; 1994 Aug; 204():68-72. PubMed ID: 7824882
    [Abstract] [Full Text] [Related]

  • 15. The identification of unusual bile acid metabolites by tandem mass spectrometry: use of low-energy collision-induced dissociation to produce informative spectra.
    Lemonde HA, Johnson AW, Clayton PT.
    Rapid Commun Mass Spectrom; 1999 Aug; 13(12):1159-64. PubMed ID: 10390861
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
    Polzien F, Ramadori G.
    J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
    [Abstract] [Full Text] [Related]

  • 19. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD.
    Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.